![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 52, 50520-50528, December 27, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
andFrom the Instituto de Investigaciones Biotecnológicas-Instituto Tecnológico de Chascomús, CONICET-UNSAM, 1650 San Martín, Provincia de Buenos Aires, Argentina
Received for publication, September 5, 2002, and in revised form, October 22, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Trypanosomes, protozoan parasites causing
worldwide infections in human and animals, mostly regulate protein
expression through post-transcriptional mechanisms and not at the
transcription initiation level. We have previously identified a
Trypanosoma cruzi RNA-binding protein named TcUBP-1. This
protein is involved in mRNA destabilization in vivo
through binding to AU-rich elements in the 3'-untranslated region of
SMUG mucin mRNAs (D'Orso, I., and Frasch, A. C. (2001) J. Biol. Chem. 276, 34801-34809). In this work
we show that TcUBP-1 is part of an ~450-kDa ribonucleoprotein complex
with a poly(A)-binding protein and a novel 18-kDa RNA-binding protein,
named TcUBP-2. Recombinant TcUBP-1 and TcUBP-2 proteins recognize
U-rich RNAs with similar specificity and affinity through the
~92-amino acid RNA recognition motif. TcUBPs can homo- and
heterodimerize in vitro through the glycine-rich C-terminal
region. This interaction was also detected in vivo by
co-immunoprecipitation of the ribonucleoprotein complex and using yeast
two-hybrid assay. The poly(A)-binding protein identified was shown to
disrupt the formation of TcUBP-1, but not TcUBP-2, homodimers in
vitro. The possible role of TcUBP-1 ligands in the pathways that
govern mRNA-stability and stage-specific expression in trypanosomes
is discussed.
Trypanosoma cruzi is the etiological agent of Chagas'
disease, an endemic illness in Latin America. The parasite has a life cycle that includes a vertebrate and an insect vector, with different developmental stages involved in each host. In the insect, two main
forms of the parasite are present: replicative epimastigotes and
metacyclic trypomastigotes. The latter form is infective to humans
after being released on the skin or mucosa with the feces of the
bug. Metacyclic trypomastigotes invade host cells and differentiate into a replicative amastigote form that differentiates into bloodstream trypomastigotes. The latter stage is able to invade a wide variety of
cells, thus propagating the infection. The cycle closes when the
hematophagous vector ingests circulating trypomastigotes with its blood
meal. Trypanosomes, protozoan parasites of the order Kinetoplastida,
have particular features in terms of mechanisms leading to protein
expression. RNA polymerase I promoters were identified in rDNA
but also in genes encoding the variable surface antigens from African
trypanosomes (1). Conversely, only few RNA polymerase II promoters were
described (2). As part of the maturation process, a common
39-nucleotide RNA, named spliced leader, is added to all trypanosome
mRNAs by a trans-splicing process. This phenomenon was
shown to be couple to 3'-poly(A) tail addition during polycistronic RNA
processing (3). As a consequence, and at variance with higher
eukaryotic cells, the control of protein expression in trypanosomatids
is mainly post-transcriptional (4). However, little information is
available on the relative importance of these processes and how they
operate jointly in the parasite.
One of the possible mechanisms to regulate protein expression is
through modification of the half-life of mRNAs. Several
cis-elements located throughout the mRNA, coding and/or
untranslated regions (UTRs),1
were identified (5-7). However, only few of them were found to be
recognized specifically by trans-acting factors (8). We have
found previously (9) two distinct cis-elements located in
the 3'UTR of the mRNAs of a mucin surface antigen family named SMUG
of T. cruzi. A 44-nucleotide AU-rich element (ARE) was shown to destabilize SMUG transcripts in the infective non-replicative trypomastigote stage of the parasite. Conversely, a 27-nucleotide G-rich cis-element stabilizes SMUG in the non-infective
replicative epimastigote stage of the parasite (8). These results
suggest that both elements, ARE and the G-rich cis-element,
act coordinately in a developmentally regulated manner and are
recognized by specific RNA-binding proteins (8). Recently, we described
that this ARE sequence was recognized by a single RRM-type RNA-binding
protein named TcUBP-1, for T. cruzi
Uridine-binding protein. In
vivo, TcUBP-1 was shown to destabilize SMUG mRNAs in the
epimastigote stage of the parasite (10). Furthermore, and at variance
with what occurs in yeast, the processes of 3'-5' and 5'-3'
exonucleolityc cleavage were shown to be active in trypanosomes (11).
The identification of an exosome in T. brucei (12) suggests
that an early mechanism of mRNA maturation, mediated by 3'-5'
exonucleases involved in 3'-end processing, might be a similar although
more primitive process, compared with that present in higher eukaryotic
cells (13). Therefore, the possibility of regulating the decay of ARE-containing mRNAs exists in trypanosomes.
In this work, we delineate TcUBP-1 involvement in mRNA maturation
processes by defining, in part, their protein ligands. We identified a
ribonucleoprotein complex containing TcUBP-1 and demonstrated that it
interacts specifically with two RRM-type RNA-binding proteins. The
first ligand identified was TcPABP1, and its effect in the recognition
of U-rich RNA by TcUBP-1 was studied. The second ligand was a novel
18-kDa U-rich RNA-binding protein named TcUBP-2. We provide evidence
for the in vitro and in vivo interaction of
TcUBP-1 with these ligands, as well as data suggesting that their
association modulates TcUBP-1 binding with U-rich RNAs.
Parasite Cultures--
T. cruzi CL-Brener
cloned stock (14) was used. Different stages of the parasite were
obtained as described previously (15).
Cloning of Tcubp-2 and RT-PCR--
During the cloning of
Tcubp-1 by RT-PCR using RNP-1 oligonucleotide
(5'-aaacttcacaatccataggcc-3') a second clone, named Tcubp-2, was identified. Another RT-PCR was done with primer
oligo(dT(18))-anchor (5'-gcgactccgcggccgcg(t)18-3'). Second strand DNA synthesis
was done with anchor and with a primer annealing at the N-terminal of
Tcubp-2, named NH2-sense (5'-atgtctcaacagatgcaatac-3'). These products were cloned in pGEM-T Easy (Promega) and sequenced in an ABI Prism 373 sequencer. The sequence reported here has been submitted to
GenBankTM with accession number AF497746.
Recombinant TcUBPs Protein Expression and
Purification--
Tcubp-1 and Tcubp-2 cDNAs and partial
deletions of both were amplified by PCR (see Table I). They were cloned
into the BamHI and EcoRI restriction endonuclease
sites of the pGEX-2T vector (Amersham Biosciences), generating a
glutathione S-transferase (GST) fusion and transformed in
Escherichia coli strain BL21 DE3 pLysS (Novagen). Cultures
were induced with isopropyl-1-thio- Antibody Production and Western Blot Analysis--
An antibody
against TcUBP-1 RRM was prepared as described (10). Two specific
peptides of TcUBP-1, VSQYDPYGQTAC, and TcUBP-2, RNRNGVSTFGAC, were
synthesized (Sigma GENOSYS). The C-terminal cysteine residues
were added to conjugate the peptides with maleimide-activated keyhole
limpet hemocyanin according to the manufacturer's instructions (Pierce). Keyhole limpet hemocyanin-conjugated peptides were injected into rabbits and mice with Freund's adjuvant three times at 2-week intervals. For Western blot analysis, samples were fractionated on
SDS-PAGE gels transferred to HybondC nitrocellulose (Amersham Biosciences), probed with primary antibodies, and developed using horseradish peroxidase-conjugated anti-rabbit and anti-mouse antibodies and the Supersignal® West Pico chemiluminescent substrate (Pierce), according to manufacturer's instructions.
Cloning of Tcpabp1 and Tcpabc Domain--
A 249-bp fragment
corresponding to Tcpabp1 C-terminal region (16) was
amplified by PCR with oligonucleotides PABC-1
(5'-ggatcctctttggcttcacagggacag-3') and PABC-2
(5'-gaattcctaaacgttcatgtggcgattc Protein Extract Preparation--
Cytosolic protein extracts and
subcellular fractionation were done as described (8).
Immunoprecipitations--
A cytosolic extract corresponding to
108 parasites or gel filtration chromatography column
fractions were incubated with mouse pre-immune serum, anti-TcUBP-1,
anti-TcUBP-2, or anti-TcPABP1 polyclonal antibodies for 2 h at
4 °C with gentle mixing. A 50% slurry of protein A-Sepharose was
added to the mixture and incubated for 2 h more. The mixture was
centrifuged at 1000 × g for 1 min, and the resin was
washed four times with 300 µl of Tris-buffered saline-Tween 0.05%.
Proteins were eluted with 2× Laemmli buffer.
Gel Filtration Chromatography--
Gel filtration was carried
out with 300 µl of an epimastigote protein extract (10 mg/ml) on a
Bio-Sil SEC 250 column (Bio-Rad). A Superdex 75 HR 10/30 (Amersham
Biosciences) was used for the determination of apparent molecular
masses of the recombinant proteins. Columns were equilibrated in 20 mM Tris-HCl, pH 6.8, and 150 mM NaCl. Fractions
of 500 µl were collected and analyzed by Western blot. Where
indicated, the extract was pre-treated with RNase A (USB) at a
concentration 0.1 µg/µl during 30 min.
Cross-linking Studies--
TcUBP-1, TcUBP-2, and the deletion
mutant proteins (Table I)
were treated at room temperature with glutaraldehyde at a final concentration of 0.01% as indicated (17). The products were run on a
SDS-PAGE and stained with Coomassie Blue.
Dihydrazide-agarose RNA Cross-linking--
Homoribopolymers (rA,
rC, rG, rU) were oxidized with NaIO4 and cross-linked to
adipic acid dihydrazide-agarose beads (Sigma) as indicated previously
(18). Purified proteins or trypanosome extracts were incubated for
1 h with RNA cross-linked beads and washed. Protein elution was
done with 2× Laemmli buffer.
In Vitro Protein Binding Experiments--
GST pull-down was
carried out with 5 µg of GST or GST fusion proteins immobilized on
glutathione beads (Sigma) and 5 µg of TcUBP-1 or TcUBP-2, without GST
tag. Columns were equilibrated with Tris-buffered saline, and after
washing with Tris-buffered saline-Triton 0.1%, eluted proteins were
loaded onto a SDS-PAGE and stained with Coomassie Blue.
In Vitro Transcription--
RNA production was done according to
previous protocols (8). The RNAs synthesized were S, P1, P2, P3, and
P1-GGG (see Fig. 5).
RNA-Protein Interactions--
Native mobility gel shift assays
were done with the indicated protein amounts and RNA as previously
described (10). All gel shift experiments were performed at least
twice. Bands were quantified using Image Analysis software (Eastman
Kodak Co.). Kd values were calculated by plotting
the ratio of bound RNA/free RNA against protein concentration.
Yeast Two-hybrid Assay--
Saccharomyces cerevisiae
L40 cells were transformed sequentially with pBTM116 plasmid expressing
a LexA-DNA-binding domain (DBD) fusion protein and pVP16 plasmid
expressing a VP16 transcription activation domain fusion protein and
were grown at 28 °C in synthetic medium Yc-TULLH (Trp Tcubp-2 Encodes a Single RRM-type RNA-binding Protein--
During
Tcubp-1 cloning (10), we also identified, by RT-PCR, a
second clone. It was named Tcubp-2 because of its identity with Tcubp-1. We demonstrated by Southern blot that
Tcubp-2 is present as a single copy gene per haploid genome
(not shown). TcUBP-2, as TcUBP-1, has a short N-terminal region. Only
20 amino acids are present in TcUBP-2, and glutamine accounts for the
majority of them (45%). A deletion of about 14 residues is present
within the N-terminal region of TcUBP-2 (Fig.
1A). The RRM motif (~92 amino acids) presents conserved RNP domains (Fig. 1, A and
B) (20), and its identity is 98% (Fig. 1A). The
C-terminal region of the RRM, 8 amino acids after TcUBP-2 Binds poly(U)-RNA and Is Expressed Differentially during
Parasite Development--
A Western blot analysis was performed with
an anti-RRM polyclonal antibody using a total parasite extract of the
epimastigote stage. The anti-RRM antibody recognized three protein
bands of 18, 27, and 45 kDa (Fig.
2A). Both 27- and 45-kDa
protein bands were suggested to be TcUBP-1 isoforms, but only the
27-kDa band has the expected size for Tcubp-1 coding region.
Previously, we observed that the 45-kDa isoform increases after
parasite transformation with Tcubp-1. This result suggested
that the 45-kDa isoform might correspond to a post-translationally
modified form of TcUBP-1 (10). To simplify the nomenclature,
TcUBP-1 will refer to the 27-kDa protein and TcUBP-1m, m from modified,
to the 45-kDa protein. To confirm that they are indeed codified by
Tcubp-1, we raised antibodies against the N-terminal region
of TcUBP-1 and named it anti-TcUBP-1 antibody. This antiserum
identified both the 27- and 45-kDa bands, signals that were
undetectable when the antiserum was pre-adsorbed with GST-TcUBP-1
protein (Fig. 2B). On the other hand, the 18-kDa protein
band corresponds to the expected size derived for Tcubp-2
coding region (165 amino acids, 18.4 kDa). To confirm whether this
protein is indeed TcUBP-2, we raised antibodies against a peptide of
its central region from the amino acids 111 to 122 (Fig. 1A)
and named it anti-TcUBP-2. This antibody recognized GST-TcUBP-2 and not
GST-TcUBP-1 (Fig. 2C). Additionally, the specificity of the
anti-TcUBP-2 antibody was demonstrated. Pre-adsorption of the antibody
with GST-TcUBP-2 abolished its interaction with the 18-kDa polypeptide
(Fig. 2C). This result demonstrated the specificity for the
anti-TcUBP-2 antibody and also confirmed that the 18-kDa protein is
indeed TcUBP-2.
TcUBP-2 expression levels were analyzed by Western blot, using total
parasite extracts from the different stages of the parasite. TcUBP-2
was detected preferentially in epimastigotes (Fig. 2D), showing that it is expressed differentially during parasite
development. As control of this experiment, the same filter was reacted
with an antibody made against the poly(A)-binding protein (16), showing that it is detected in all stages of the parasite. To verify whether TcUBP-2 presents functional RNA-binding activity, an in
vitro binding assay was performed. The homoribopolymers (rA, rC,
rG, and rU) were cross-linked to dihydrazide-agarose beads. A
trypanosome total protein extract from the epimastigote stage was
prepared and passed through the four columns, and the eluted proteins
were run in SDS-PAGE, followed by Western blot using an anti-RRM
antibody. TcUBP-2, as TcUBP-1 isoforms, was recognized only in the
fraction bound to poly(U) column and not to other homoribopolymers
(Fig. 2E). The cellular localization of TcUBPs proteins was
performed by a biochemical fractionation, demonstrating that they are
located preferentially in the polysomal fraction (not shown).
A Ribonucleoprotein Complex Containing TcUBP-2 and the
Destabilizing Factor TcUBP-1--
Because TcUBP-1 was shown to be
involved in post-transcriptional regulation (10), it might exert its
effect through protein-protein interactions. Thus, we asked whether
TcUBP-1 forms a protein complex in vivo in the epimastigote
stage. Gel filtration experiments were performed with cell-free
extracts pre-treated with Buffer A (150 mM NaCl) and Buffer
B (150 mM NaCl, ~0.1 µg/µl RNase A). After
pre-treatment of the extracts for 30 min, they were applied on a
Bio-Sil SEC 250 column, and the eluates were analyzed by Western blot
using anti-RRM antibody. In the treatment of the extract with Buffer A,
we observed that TcUBP-1 isoforms and TcUBP-2 were detected in a high
molecular mass RNA-protein complex of ~450 kDa (Fig.
3A, lane 9).
TcUBP-1 was also detected in fraction 17 of an apparent molecular mass
of ~27 kDa. This band might correspond to the monomer form.
Conversely, TcUBP-2 was detected between fractions corresponding to 17 and 45 kDa (Fig. 3A, lanes 16-19) and also in
fraction 12 of ~250 kDa. In the presence of Buffer B, all protein
bands from the fraction corresponding to the ~450-kDa complex
disappeared (Fig. 3B, lane 9), whereas the
position of TcUBP-1 and TcUBP-2 in between fractions 16 and 19 did not
change significantly. Thus, because Buffer B contains RNase A, these results suggest that an RNA component might be important for the RNA-protein interactions and complex formation. The amount of a
trypomastigote stage protein extract used in two different gel chromatography experiments did not allow the detection of bands in
Western blot analysis (not shown).
The RNA-Protein Complex Contains TcUBP-1/TcUBP-2
Heterodimer and TcPABP1--
To determine whether TcUBP-1 and TcUBP-2
proteins interact in vivo, as suspected from the gel
chromatography profiles from Fig. 3A, immunoprecipitation
experiments were performed. Fraction 9 in Fig. 3A
was pre-treated or not for 30 min with RNase A and immunoprecipitated with pre-immune, anti-TcUBP-1, or anti-TcUBP-2 polyclonal antibodies followed by a Western blot using the anti-RRM antibody (Fig. 4A). Both
TcUBP-1 and TcUBP-2 were detected independently of the treatment of the
extract with RNase, suggesting that they were associated in
vivo by protein-protein interaction. However, it was difficult to
detect TcUBP-1m under these experimental conditions (Fig.
4A). TcUBP-1 and TcUBP-2 homo- and heterodimerization was corroborated through a two-hybrid assay, performed in L40 yeast strain and using LexA-DNA binding and VP16 activation domain hybrid proteins (see below).
In higher eukaryotic cells, PABP1 protein is part of a multiprotein
complex formed in the 3'UTR of ARE-containing mRNAs (21). Because
TcUBP-1 binds to SMUG 3'UTR and regulates its mRNA stability levels, we asked whether TcPABP1 might be present in this complex. An
immunoprecipitation was carried out with anti-TcUBP-1, anti-TcUBP-2, or
anti-TcPABP1 antibodies followed by a Western blot using the anti-TcPABP1 antibody. We found evidence that the ribonucleoprotein complex containing the heterodimer also contains TcPABP1 (Fig. 4B). Although two different bands of 55 and 66 kDa were
detected, the 66-kDa band was described as being TcPABP1 (16).
TcUBP-1 and TcUBP-2 Interact in Vivo in a Two-hybrid System--
A
two-hybrid assay was performed to corroborate TcUBP-1 homo- and
heterodimerization with TcUBP-2 in a heterologous system. The coding
sequence of TcUBP-1 was fused to the LexA-DBD in the plasmid
pBTM116 to serve as bait (19). Alone, LexA-DBD-TcUBP-1 did not give any
detectable levels of GAL4-dependent synthesis of lacZ in
the L40 yeast strain used (not shown). Therefore, TcUBP-1 and TcUBP-2
cDNAs were cloned into the pVP16 fused to VP16 activation domain.
We test them in binding assay with LexA-DBD-TcUBP-1. The co-transformation of L40 yeast strain with LexA-TcUBP-1 and
VP16-TcUBP-1 or VP16-TcUBP-2 allowed the growth of transformants on
medium without histidine and also displays lacZ activity (not
shown). Negative results were obtained with control yeast transformed with LexA-DBD-TcUBP-1 and VP16 alone. Thus, the interaction between TcUBP-1/TcUBP-1 and TcUBP-1/TcUBP-2 was specific. These results demonstrate that TcUBP-1 and TcUBP-2 proteins have the potential to
interact in vivo in a heterologous system, corroborating the immunoprecipitation results (Fig. 4A).
Interaction between TcUBP Proteins and TcPABP1 in Different Stages
of Differentiation--
We next analyzed the interaction of TcUBPs and
TcPABP1 throughout parasite development. Total trypanosome extracts
were prepared from the different parasite stages, incubated with
anti-TcUBP-1 antibody for immunoprecipitation, followed by Western blot
with anti-TcPABP1. This experiment demonstrated that TcUBP-1 interacts with TcPABP1 in the epimastigote and trypomastigote stages (Fig. 4C). Conversely, TcUBP-2 co-precipitates with TcPABP1 in the
epimastigote stage (Fig. 4B) and not in other parasite
stages (not shown). Because the complex containing TcUBPs in
epimastigotes was disrupted by RNase A treatment (Fig. 3B),
we asked whether the interaction between TcUBP-1 and TcPABP1 in this
stage was dependent on RNA. Immunoprecipitations were done with
anti-TcUBP-1 antibody using cell-free extracts pre-treated or not for
30 min with RNase A. When the extract was RNase-treated there was no
detectable TcPABP1 in the immunoprecipitate (Fig. 4D).
Conversely, in the trypomastigote stage the interaction was not
dependent on RNA, showing that TcUBP-1 and TcPABP1 make direct
protein-protein contact.
TcUBP-1 and TcUBP-2 Present the Same Binding Affinity and
Specificity to Homoribopolymers and U-rich RNA--
The binding
specificity of TcUBP-2 was tested and compared with TcUBP-1. An
electrophoresis mobility shift assay (EMSA) was performed with a
labeled U-rich element named P1, in the presence of different amounts
of each of the four homoribopolymers (Fig. 5B). We found that TcUBP-1 and
TcUBP-2 RNA-binding activity was competed in a
concentration-dependent manner with poly(U) and not by
poly(A) or poly(C). In addition, it can be competed at high
concentrations (500×) of poly(G) (Fig. 5B). These results confirmed that recombinant proteins recognize poly(U) RNA, as do the
native ones (see Fig. 2E).
Different U-rich RNAs were used to determine by EMSA the apparent
dissociation constants (Kd) of the ribonucleoprotein complexes formed by TcUBP-2 and TcUBP-1 (Fig. 5). The apparent Kd for each reaction was calculated by determining
the protein concentration at which 50% of the RNA was bound. TcUBP-2 recognized P1 RNA with an apparent Kd of ~100
nM, and TcUBP-1 recognized it with a Kd
of ~150 nM. A new RNA, which has three uridine to
guanosine changes in the last U-rich stretch of P1, was made and named
P1-GGG (see Fig. 5A). These changes had a slight effect on
TcUBP-2 Kd (~200 nM) and TcUBP-1
Kd (~250 nM). As it was described with
TcUBP-1 (10), the S RNA (see Fig. 5) is bound by TcUBP-2 with a
slightly high Kd (~250 nM).
Conversely, P2 and P3 RNAs (Fig. 5), which have shorter U-rich
stretches, were recognized by TcUBP-2 but with lower
affinities (Kd values of ~750 and ~850
nM, respectively) (Table II).
These results suggest that U-rich stretches are the most important
component of the RNA recognized by TcUBPs proteins. Also, GU-rich RNAs
are better recognized than AU-rich sequences, and the RNA-binding
activity of TcUBP-1 was clearly similar to TcUBP-2 (Fig. 5,
C and D). A summary of TcUBPs RNA-binding
activities is shown in Table II. This comparison reflects that
TcUBP-1 and TcUBP-2 have similar Kd values to
the U-rich RNAs tested in this work.
Mapping of the Minimal Region Required for RNA Binding in TcUBPs
Proteins--
We demonstrated that TcUBP-1 and TcUBP-2 recognized the
P1 RNA with similar apparent Kd values (Fig. 5).
These results suggest that the differences in the primary sequence
between both proteins might not contribute to RNA recognition and/or
modulation of the RNA-binding activity. In addition, TcUBP-1 and
TcUBP-2 dimerize when binding to RNA containing U-rich regions,
and therefore, we hypothesize that the auxiliary domains might be
crucial for their function in protein-protein interaction. To verify
this hypothesis, several deletion mutants were constructed by PCR
(Table I). The different proteins were named TcUBP-1
The predicted secondary structure and heteronuclear-nuclear Overhauser
efffect NMR spectra of
TcUBPs2 suggest that the
auxiliary domains behave as random-coil, so none of these deletions
should have any effect on TcUBP-1 and TcUBP-2 final folding. The
apparent Kd values of all TcUBPs constructions were determined by EMSA. The majority of them present similar Kd values of ~100-200 nM (Fig. 6,
B and D). However, TcUBP-1 The Glycine-rich Region of the Auxiliary Domain Is Critical for
Dimerization--
A decrease in the mobility of the ribonucleoprotein
complex formed in the presence of protein amounts greater than 500 nM was observed with TcUBP-1 and all mutant proteins except
for TcUBP-1 The Formation of TcUBP-1, but Not TcUBP-2, Homodimers Is Disrupted
by TcPABP1 Interaction in Vitro--
We have shown previously that
TcPABP1 interacts in vivo with TcUBPs proteins in both
epimastigote and trypomastigote stages (Fig. 4). Thus, we asked whether
this interaction is also detected in vitro. For these
propose, Tcpabp1 was cloned and expressed as a GST fusion
protein, rendering GST-TcPABP1. To determine whether TcUBP-1 and
TcUBP-2, without GST tag, interact in vitro with
GST-TcPABP1, a GST pull-down assay was done. Under the same assay
conditions, GST-TcPABP1 interacts with TcUBP-1 but failed to interact
with TcUBP-2 (Fig. 8A),
suggesting that the binding of TcUBP-1 to TcPABP1 is mediated by
protein-protein interactions and not mediated by RNA (Fig.
8A). We also analyzed by EMSA the effect of adding
increasing concentrations of TcPABP1 in TcUBP-1 and TcUBP-2 U-rich
RNA-binding assays. To ensure complete RNA recognition, ~2
µM TcUBP-1 and TcUBP-2 proteins were used. Although no
observable effect was detected on TcUBP-2 RNA-binding, TcUBP-1-binding
activity was modified by increasing concentrations of TcPABP1 (Fig.
8B). TcPABP1 did not displace TcUBP-1 protein from RNA,
because no free RNA is detected at high amounts. Conversely, it
disrupted or knocked out dimer formation on U-rich RNA, rendering a
monomeric RNA recognition pattern in solution (Fig. 8B).
TcUBP-1 interaction with TcPABP1 might involve N- or C-terminal regions
of TcUBP-1, because these regions are different between TcUBP-1
and TcUBP-2.
In this work we have provided evidence for the existence of two
very closely related RNA-binding proteins, TcUBP-1 and TcUBP-2, that
present an identical RRM motif with distinct N- and C-terminal regions.
The C-terminal region of TcUBP-1 can be divided into two parts, a short
glycine-rich region and a large glutamine-rich random-coil domain.
Conversely, TcUBP-2 presents a glycine-rich region larger and with
three YGG motives (Fig. 1). TcUBP-1 presents affinity for U-rich
elements in vitro and in vivo (10; and this work), and both proteins recognize with high affinity AU- and GU-rich
elements. Our ongoing NMR structure of TcUBP-1 and TcUBP-2 suggest that
they present a similar Of great importance is the modular RRM organization of RNA-binding
proteins in higher eukaryote cell types. They present multiple RRM
motifs, and its composition is what determines the final affinity for
the RNA. The first RRM (RRM1) is the most important in terms of RNA
affinity and specificity. However, the other RRM motifs have an
accessory function, such as oligomerization and localization (25),
structure stability in solution (23), and protein-protein interaction
(26). Analysis of HuR deletion mutants allowed Park et al.
(27) to suggest that RRM1 is critical for ARE binding but that at least
one additional RRM is required to achieve a Kd in
the nanomolar range. Both RRM1 and RRM2 are important for ARE affinity,
even though they are not sufficient (24). It is important to conclude
that certain RNA-binding proteins require only one domain to achieve
RNA-binding specificity and affinity, such as U1A (28). Conversely,
other proteins have been shown to require combinations of at least two
(27) or occasionally more domains (29). Several common features have
emerged from the comparison of two tandem RRM structures such as those
in Sxl (30) and PABP1 (31). Each of these proteins contains short interdomain linkers of about 8-11 residues. These regions are highly
mobile in the free protein making the two domains structurally independent (32).
Homodimerization, the common feature of prokaryotic transcription
factors, is extended in eukaryotes by heterodimerization. This
possibility increases the range of DNA sequences that can be recognized
and the degree of binding specificity. In evolutionary terms, this
increase in range is necessary when genomes become larger and more
complex (33). We have provided here evidence demonstrating that the
glycine-rich region of TcUBPs is important for dimerization (see Figs.
6 and 7). However, the fact that no dimers can be detected by
cross-linking with TcUBP-1, at difference with TcUBP-1 TcUBP-1 and TcUBP-2 form part of a ribonucleoprotein complex containing
TcPABP1. TcUBP-2 co-precipitates in the epimastigote stage, whereas
TcUBP-1 precipitates with TcPABP1 in epimastigote and trypomastigote
stages (Fig. 4). In vitro, TcUBP-1 interacts with TcPABP1,
in the absence of RNA, and the effect of this interaction was to
disrupt the formation of TcUBP-1, but not TcUBP-2, homodimers (Fig. 8).
The domains involved in these interactions have not been identified.
However, we speculate that the C terminus of TcUBP-1 might be involved,
because this is the most dissimilar region when comparing with TcUBP-2.
Although TcUBP-1 lacks the PABC consensus sequence described for PABP1
partners in human (36), this possibility must be tested further. In
higher eukaryotes, when complexed to the poly(A)-tail, PABP1
circularizes mRNA molecules via its interaction with translational
initiation factors, which results in mRNA stabilization (21).
Recently, it has been shown that binding of some AU-rich-binding
proteins to ARE may alter the interaction between PABP1 and the
poly(A)-tail, thereby providing access to a poly(A)-ribonuclease (37).
Rapid mRNA degradation involves the recognition of AREs by
AU-rich-binding proteins, several of which have been shown to recruit
the exosome and cause the reduction of PABP1 affinity for the
poly(A)-tail (37). In our model (Fig. 9),
the interaction of TcUBP-1 and TcPABP1 in vitro disrupts the
formation of TcUBP-1 homodimers and might also change the affinity of
TcPABP1 for the poly(A)-tail. The possibility that in trypomastigotes,
the presence of TcUBP-1 protein without TcUBP-2 on SMUG 3'UTR may
recruit the exosome or a poly(A)-ribonuclease activity (Fig. 9), is
unlikely (21). We suggest that, in the epimastigote stage, the presence
of TcUBP-2 and other yet unidentified factors might stabilize the
interaction between TcUBP-1 and TcPABP1 within the ribonucleoprotein
complex. This can prevent, at least in part, the disruption of TcUBP-1
homodimers (Fig. 8). Although our results provide evidence for the role
of these ARE-binding proteins in the regulation of mRNA turnover in
trypanosomes, establishing the mechanism by which TcUBPs stimulate
mRNA stabilization/destabilization will require additional
experiments.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-galactopyranoside for 3 h at 37 °C. Recombinant proteins were purified using
GST-agarose columns (Sigma). GST fusion proteins were cleaved with
thrombin (Sigma). The reactions were performed with 1 unit of
thrombin/100 µg of protein in a buffer containing 20 mM
Tris-HCl, pH 7.6, 150 mM ClNa, and 2.5 mM
Cl2Ca during 2 h at 25 °C.
3') and was named Tcpabc (introduced EcoRI and BamHI
sites are underlined). Tcpabp1 was amplified by PCR with
primer PABP-N (5'-ggatccatgtcgaactttcctgctgcg-3') and
PABC-2. Both products were cloned into pGEX-2T vector (Amersham Biosciences) and induced as indicated above. An antibody against TcPABC
was raised and named anti-TcPABP1.
Constructions made for TcUBP-1 and TcUBP-2 protein deletions
,
Ura
, Leu
, Lys
,
His
) (19). An interaction between the DBD and the
activation domain of the fusion proteins results in the production of
the HIS3 gene product and enables the cells to grow on minimal medium
lacking histidine.
-Galactosidase assays were carried out as
described previously (19). Plasmids pBTM116 and pVP16 were a kind gift from Dr. Tellez-Inon (Instituto de Investigaciones en
Ingeniería Genética y Biología Molecular).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
4 sheet (Fig.
1A), is different between TcUBP-1 and TcUBP-2. Therefore, we
named this sequence variable region (VR). Finally, a glycine-rich
C-terminal region, with YGG motives, is present in TcUBP-2 (Fig.
1A). TcUBP-2 C-terminal is shorter than that of TcUBP-1 and
lacks the glutamine-rich random-coil region (10).

View larger version (56K):
[in a new window]
Fig. 1.
TcUBP-1 and TcUBP-2, two RRM-type RNA-binding
proteins with different auxiliary domains. A,
comparison of TcUBP-1 and TcUBP-2 proteins derived from cDNA
sequence. The alignment was done using ClustalW (38). Gly- and Gln-rich
regions and the RNP-2 and RNP-1 sequences within the RRM motif are
indicated. The predicted
and
secondary structures are shown as
determined (www.embl-heidelberg.de/predictprotein/). B,
scheme of TcUBP-1 and TcUBP-2 proteins showing the RRM, VR, Gly-rich
region (GLY), and Gln-rich region (GLN).

View larger version (34K):
[in a new window]
Fig. 2.
TcUBP-2 is differentially expressed during
development and binds poly(U)-RNA. A, Western blot
analysis performed on an epimastigote stage protein extract with an
anti-RRM antibody. The positions of the proteins identified (18, 27, and 45 kDa) are indicated with arrows. B, Western blot
performed with an anti-TcUBP-1 antibody. Lane 1,
epimastigote stage protein extract; lane 2, GST-TcUBP-1;
lane 3, GST-TcUBP-2; and lane 4, epimastigote
stage protein extract reacted with the anti-TcUBP-1 antibody
preadsorbed with GST-TcUBP-1. C, Western blot performed with
an anti-TcUBP-2 antibody. Lane 1, epimastigote stage protein
extract; lane 2, GST-TcUBP-2; lane 3,
GST-TcUBP-1; and lane 4, epimastigote stage protein extract
reacted with the anti-TcUBP-2 antibody preadsorbed with GST-TcUBP-2.
D, a Western blot with protein extract of the life cycle
stages of T. cruzi (E, epimastigotes;
T, cell-derived trypomastigotes; and A,
amastigotes) was performed with an anti-TcUBP-2 antibody. The same
filter was reacted with an anti-TcPABP1 antibody. E, an
epimastigote stage protein extract was prepared and incubated with
dihydrazide-agarose beads alone (beads) or cross-linked with
homoribopolymers (A, C, G, or
U). After washing and elution a Western blot was performed
with the anti-RRM antibody.

View larger version (33K):
[in a new window]
Fig. 3.
TcUBP-1 and TcUBP-2 are present in an
~450-kDa ribonucleoprotein complex. An epimastigote protein
extract was prepared and pre-treated for 30 min at 25 °C as
indicated. A, 150 mM NaCl; B, 150 mM NaCl and ~0.1 µg/µl RNase A in a 20 mM
Tris-HCl, pH 6.8, buffer. The different extracts were applied to a
BioSil SEC250 gel chromatography column, and fractions of 0.5 ml were
collected. They are indicated as Gel Chromatography Fractions
above each panel. Samples were then analyzed by Western
blot with an anti-RRM antibody. The position of TcUBP-1, TcUBP-1m, and
TcUBP-2 protein is indicated with arrows. Ext,
refers to the protein extract before applying to the column. In
fractions 1 to 7, no proteins cross-reacting with the antibody were
detected (not shown). The molecular mass markers used in the Gel
Chromatography column are indicated above each
panel as follows: 670 kDa, tyroglobulin;
180 kDa,
2-macroglobulin; 45 kDa, ovalbumin;
17 kDa, myoglobin.

View larger version (29K):
[in a new window]
Fig. 4.
TcUBP-1 and TcUBP-2 interact and are
complexed with poly(A)-binding protein. A, an
epimastigote protein extract was pretreated (+) or not (
) with RNase
A for 30 min and incubated with pre-immune or anti-TcUBP-1 antibodies,
as indicated above the panel (IP). The
immunocomplexes were precipitated with protein A-Sepharose. Samples
were resolved and analyzed by Western blot with anti-RRM antibody.
IgG hc indicates the position of immunoglobulin heavy chain.
B, an epimastigote total protein extract was incubated with
pre-immune, anti-TcUBP-1, anti-TcUBP-2, or anti-TcPABP1 antibodies. The
immunocomplexes were precipitated with protein A-Sepharose. Samples
were electrophoresed and analyzed by Western blot with anti-TcPABP1
antibody. The presence of TcPABP1 and IgG hc is indicated with
arrows. A protein band of ~55 Da cross-reacts with the
antibody. C, epimastigote (E), trypomastigote
(T), and amastigote (A) protein extracts were
incubated with anti-TcUBP-1 antibody. The co-precipitates were reacted
with anti-TcPABP1 antibody. D, epimastigote and
trypomastigote protein extracts were pre-treated (+) or not (
) with
RNase A and precipitated with anti-TcUBP-1 antibody and protein
A-Sepharose. The co-precipitates were probed with anti-TcPABP1
antibody. In panels C and D, the band
corresponding to the IgG hc is not detectable because of the lower
exposure time of the film.

View larger version (36K):
[in a new window]
Fig. 5.
TcUBP-1 and TcUBP-2 bind U-rich RNAs with
similar specificity and affinity. A, sequences of the
RNAs used in the EMSA experiments. B, an EMSA with ~1
µM TcUBP-1 or TcUBP-2 and P1 RNA was performed and
competed with increasing amounts of homoribopolymers (1, 10, 50, and
500×). RNA, binding reaction without protein; (
), binding
reaction without unlabelled competitor. C, an EMSA was
performed to determine the apparent dissociation constants between
TcUBP-2 and the indicated RNAs. D, EMSA to determine the
apparent dissociation constants between TcUBP-1 and the indicated RNAs.
The amount of proteins used in panels C and D
were 0, 10, 50, 250, 500, and 1000 nM as indicated.
Comparison between the Kds of TcUBP-1 and TcUBP-2
N, lacking the N-terminal region; TcUBP-1
Q, lacking the glutamine-rich region; TcUBP-1
NQ, lacking its N- and glutamine-rich regions; and two other
constructs named TcUBP-1
QG1 and TcUBP-1
QG2 (Fig.
6A). The difference between
these two last deletion mutants resides in their VR. The first one has
this portion, composed by 14 extra amino acids (PGIAGAVGDGNGYL), after
the predicted
4 sheet (Fig. 6A). However, both lack the
motif GAYGGYGAY within the glycine-rich region. Similarly, TcUBP-2
deletions were TcUBP-2
N, lacking the N-terminal region; TcUBP-2
C,
which lacks the C-terminal region; and TcUBP-2
CG1 and TcUBP-2
CG2
(Fig. 6C). The difference between these two last proteins is
that the first one presents the VR region, composed by nine extra amino
acids (NRNGVSTGF), in the C-terminal region.

View larger version (25K):
[in a new window]
Fig. 6.
Mapping of the minimal region required for
RNA binding in TcUBPs proteins. A, scheme of TcUBP-1
and mutant proteins used in the EMSA of panel B. The
position of the RRM, VR, Gly-rich region (Gly), and Gln-rich
region (Gln) is indicated above the TcUBP-1
scheme. B, EMSA to determine an apparent
Kd between TcUBP-1, or mutant proteins, and P1-RNA.
An apparent Kd was calculated from the different
curves of RNA-bound/RNA-free (%) versus protein
concentration (nM) and is indicated below each
panel. C, scheme of TcUBP-2 mutant proteins used
in the EMSA of panel D. The position of each module is
indicated as in panel A. C-terminal region (Ct)
is indicated above the TcUBP-2 scheme. D, EMSA to
determine an apparent Kd between TcUBP-2 or mutant
proteins and P1-RNA. An apparent Kd was calculated
as in B and is indicated below each
panel.
QG2 showed a
Kd >1000 nM (Fig. 6B),
showing that the RNA affinity of this mutant is decreased more than
5-fold. Conversely, TcUBP-1
QG1 that contains the VR region at the
C-terminal of the RRM motif showed the same Kd as
the complete TcUBP-1 protein. Similarly, all TcUBP-2 mutants, except
for TcUBP-2
CG2, interact with RNA with the same affinity as the wild
type TcUBP-2 protein (Fig. 6D). These experiments
demonstrate that the ~92-amino acid RRM motif is the minimal region
required for RNA binding in TcUBPs proteins. The function of C-terminal
VR extension in the RRM motif require further investigation. It might
be homologous to that of the RRM C-terminal extension present in
RNA-binding proteins from other cell types (see "Discussion").
QG1 and TcUBP-1
QG2 (Fig. 6). Both proteins lack the
glycine-rich region. Thus, these results suggest that this region might
be important for dimerization. To study the formation of dimers
in vitro, we performed cross-linking reactions with
glutaraldehyde at a final concentration of 0.01% (Fig.
7). This is a zero-length cross-linker
reagent that was described to form covalent bonds between proteins that
are in contact (17). For this purpose, different TcUBP-1 mutant
proteins listed in Fig. 7A were analyzed. Dimers were
detected at concentrations greater than 500 nM (not shown).
TcUBP-1
Q protein, which presents the VR- and glycine-rich regions
within the C-terminal, was cross-linked efficiently (Fig. 7B, lane 4). The percentage of cross-linking in
this protein was about 10-15%. Similar values of cross-linking were
obtained with proteins from other cell types (17). Conversely,
TcUBP-1
QG1 mutant protein formed dimers much less efficiently than
TcUBP-1
Q (Fig. 7B, compare lanes 4 and
6), and TcUBP-1
QG2 did not react with the cross-linker
(Fig. 7B, lane 8). The formation of dimers in
TcUBP-1 was hardly detectable with the amount of protein used in this
assay (Fig. 7B, lane 2). It might be possible
that its C-terminal glutamine-rich region regulates protein contacts
negatively because of its presumed random-coil nature (see
"Discussion"). Finally, the same cross-linking results were
obtained with TcUBP-2 and its mutant proteins (not shown), suggesting
that the glycine-rich region is the principal domain of both proteins
required for dimer formation. A chromatographic analysis was performed
to corroborate dimer formation on TcUBPs proteins. A similar elution
profile was detected with TcUBP-1
Q and TcUBP-2
C. Both elute at a
position corresponding to dimer and monomer forms (not shown), thus
confirming the dimerization results.

View larger version (25K):
[in a new window]
Fig. 7.
The glycine-rich region is critical for
dimerization of TcUBPs proteins. A, scheme of TcUBP-1
and mutant proteins used for the cross-linking studies. The position of
wild type GAYGGYGAY sequence is indicated above the TcUBP-1
scheme. B, the proteins of panel A (~1
µM) were incubated (+) or not (
) with 0.01%
glutaraldehyde. Samples were resolved by SDS-PAGE and stained with
Coomassie Blue. Position of monomer and dimer forms is indicated with
arrows at the right of the panel. The
asterisk (*) indicates the position of TcUBP-1 dimer. The
position of each lane is indicated below the figure.

View larger version (15K):
[in a new window]
Fig. 8.
Protein-protein interaction between TcUBP-1
and TcPABP1. A, GST pull-down assay between GST or
GST-TcPABP1 and TcUBP-1 or TcUBP-2 proteins, in the absence of RNA.
Input, 10% of the protein added to the pull-down assay. The
integrity of the unbound proteins was monitored by SDS-PAGE after
reaction was completed (not shown). B, an EMSA with TcUBP-1
or TcUBP-2 proteins and P1 RNA was performed. The effect of increasing
amounts of TcPABP1 (100, 250, 500, and 1000 nM) was tested.
The position of the monomer and dimer forms is indicated.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES





topology. Thus, this might
explain why both proteins present similar Kd
values with the RNAs used for the EMSA experiments (see Table II).
Although the RRM is almost identical, the C-terminal extension of this motif, named VR region, is different, and it might have a regulatory role. Deletion of the VR region produces an increase in the apparent Kd in both TcUBPs proteins (Fig. 6). Similarly, an
NMR and biochemical study of U1A RRM motif but lacking its C-terminal extension showed that it has the same folding topology but does not
bind RNA (22). Moreover, these residues were involved in structure
stability of the free protein (23). In heterogeneous nuclear RNP-D, the
C-terminal of RRM2 was important in conferring high affinity for ARE
binding (24). This phenomenon suggests that those residues localized in
the VR region might be important in conferring structure stability by a
possible interaction with residues in the
1
3 sheets that make
contact with the RNA.
Q (Fig. 7),
suggests that its C-terminal region might regulate the accessibility
and interaction with itself and/or other proteins. It was described
that shorter coiled-coils of some transcription factors might either
promote or prevent formation of homo- and/or heterodimers (33). Thus,
it is likely that in the parasite both homo- and heterodimerization
might be regulated processes. In this work we showed that TcUBPs,
having a single RRM motif, bind RNA with high affinity and
can dimerize by the glycine-rich flexible region. Thus, an even higher
affinity might be achieved in vivo through homo- and/or
heterodimerization of TcUBPs, allowing the simultaneous binding of two
RRMs to the RNA. The glycine-rich region might contribute to the
mobility and flexibility of the RRM motif in the dimer form, as deduced
from our results and comparison with RRM-type proteins in other cell
types. In general terms, the glycine-rich domains found in several
RNA-binding proteins do not have any structural features beyond the
likelihood that stretches of residues such as Gly or Pro result in
flexible coils. This region was demonstrated to be involved in
protein-protein interactions and to contribute to the RNA-binding free
energy (34, 35).

View larger version (16K):
[in a new window]
Fig. 9.
Model of the interactions among TcUBP-1,
TcUBP-2, and TcPABP1 on RNA during parasite development. In the
epimastigote stage, TcUBP-1 and TcUBP-2 form a complex with TcPABP1
within SMUG 3'UTR AU-rich element. The presence of these proteins, with
other yet unidentified factors (?), might stabilize the
ribonucleoprotein complex and lead to mRNA stabilization.
Conversely, in the trypomastigote stage TcUBP-2 is not expressed. In
fact, TcUBP-1 can interact directly with TcPABP1 in the absence of RNA.
This interaction produces the disruption of TcUBP-1 homodimers and
probably reduces the affinity of TcPABP1 for the poly(A)-tail, leading
to mRNA decay. This might be because of exosome and/or
poly(A)-ribonuclease activity recruitment. SL,
mRNA 5'-end spliced leader.
| |
ACKNOWLEDGEMENTS |
|---|
We are indebted with Fabio Fraga for animal care, Berta Franke de Cazzulo and Liliana Sferco for parasite cultures, Andrea Meras for HPLC technical assistance, and S. Lotito for helping in the yeast two-hybrid assay. We are also thankful to Drs. Imed-Eddine Gallouzi and Kalle Gehring (Department of Biochemistry, McGill University), Juan J. Cazzulo, and Graciela Gotz for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by grants from the World Bank/UNDP/WHO Special Program for Research and Training in Tropical Diseases (Tropical Disease Research) and by the Agencia Nacional de Promoción Científica y Tecnológica (Argentina).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF497746.
Supported in part by an International Research Scholars Grant from
the Howard Hughes Medical Institute and a fellowship from the John
Simon Guggenheim Memorial Foundation. Researcher from the National
Research Council (CONICET), Argentina.
§ Research fellow from the National Research Council (CONICET), Argentina. To whom correspondence should be addressed: IIB-UNSAM, INTI, Av. Gral. Paz s/n, Edificio 24, Casilla de Correo 30, 1650 San Martín, Provincia de Buenos Aires, Argentina. Tel.: 54-11-4580-7255; Fax: 54-11-4752-9639; E-mail: cfrasch@iib.unsam.edu.ar.
Published, JBC Papers in Press, October 25, 2002, DOI 10.1074/jbc.M209092200
2 I. D'Orso et al., manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: UTR, untranslated region; ARE, AU-rich element; RRM, RNA-recognition motif; RT, reverse transcription; RNP, ribonucleoprotein; GST, glutathione S-transferase; DBD, DNA-binding domain; VR, variable region; EMSA, electrophoresis mobility shift assay.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Vanhamme, L.,
and Pays, E.
(1995)
Microbiol. Rev.
59,
223-240 |
| 2. |
Gilinger, G.,
and Bellofatto, V.
(2001)
Nucleic Acids Res.
29,
1556-1564 |
| 3. |
Matthews, K. R.,
Tschudi, C.,
and Ullu, E.
(1994)
Genes Dev.
8,
491-501 |
| 4. | Clayton, C. E. (2002) EMBO J. 21, 1881-1888[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Hehl, A.,
Vassella, E.,
Braun, R.,
and Roditi, I.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
370-374 |
| 6. | Nozaki, T., and Cross, G. A. (1995) Mol. Biochem. Parasitol. 75, 55-67[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Weston, D., La, Flamme, A. C., and Van Voorhis, W. C. (1999) Mol. Biochem. Parasitol. 102, 53-66[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
D'Orso, I.,
and Frasch, A. C.
(2001)
J. Biol. Chem.
276,
15783-15793 |
| 9. |
Di Noia, J. M.,
D'Orso, I.,
Sanchez, D. O.,
and Frasch, A. C.
(2000)
J. Biol. Chem.
275,
10218-10227 |
| 10. |
D'Orso, I.,
and Frasch, A. C.
(2001)
J. Biol. Chem.
276,
34801-34809 |
| 11. |
Irmer, H.,
and Clayton, C.
(2001)
Nucleic Acids Res.
29,
4707-4715 |
| 12. | Estevez, A. M., Kempf, T., and Clayton, C. (2001) EMBO J. 20, 3831-3839[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Wang, Z., and Kiledjian, M. (2001) Cell 107, 751-762[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Zingales, B., Pereira, M. E., Almeida, K. A., Umezawa, E. S., Nehme, N. S., Oliveira, R. P., Macedo, A., and Souto, R. P. (1997) Mem. Inst. Oswaldo Cruz 92, 811-814[Medline] [Order article via Infotrieve] |
| 15. |
Di Noia, J. M.,
D'Orso, I.,
Aslund, L.,
Sanchez, D. O.,
and Frasch, A. C.
(1998)
J. Biol. Chem.
273,
10843-10850 |
| 16. | Batista, J. A., Teixeira, S. M., Donelson, J. E., Kirchhoff, L. V., and de Sa, C. M. (1994) Mol. Biochem. Parasitol. 67, 301-312[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Wan, L.,
Kim, J. K.,
Pollard, V. W.,
and Dreyfuss, G.
(2001)
J. Biol. Chem.
276,
7681-7688 |
| 18. | Caputi, M., Mayeda, A., Krainer, A. R., and Zahler, A. M. (1999) EMBO J. 18, 4060-4067[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Fields, S., and Song, O. (1989) Nature 340, 245-246[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Burd, C. G.,
and Dreyfuss, G.
(1994)
Science
265,
615-621 |
| 21. | Wilusz, C. J., Wormington, M., and Peltz, S. W. (2001) Nat. Rev. Mol. Cell. Biol. 2, 237-246[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Lu, J., and Hall, K. B. (1995) J. Mol. Biol. 247, 739-752[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Avis, J. M., Allain, F. H., Howe, P. W., Varani, G., Nagai, K., and Neuhaus, D. (1996) J. Mol. Biol. 257, 398-411[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | DeMaria, C. T., Sun, Y., Wagner, B. J., Long, L., and Brewer, G. A. (1997) Nucleic Acids Symp. Ser. 36, 12-14 |
| 25. | Perez, I., McAfee, J. G., and Patton, J. G. (1997) Biochemistry 36, 11881-11890[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Khaleghpour, K.,
Kahvejian, A., De,
Crescenzo, G.,
Roy, G.,
Svitkin, Y. V.,
Imataka, H.,
O'Connor-McCourt, M.,
and Sonenberg, N.
(2001)
Mol. Cell. Biol.
21,
5200-5213 |
| 27. |
Park, S.,
Myszka, D. G., Yu, M.,
Littler, S. J.,
and Laird-Offringa, I. A.
(2000)
Mol. Cell. Biol.
20,
4765-4772 |
| 28. |
Klein Gunnewiek, J. M.,
Hussein, R. I.,
van Aarssen, Y.,
Palacios, D.,
de Jong, R.,
van Venrooij, W. J.,
and Gunderson, S. I.
(2000)
Mol. Cell. Biol.
20,
2209-2217 |
| 29. | Perez-Canadillas, J. M., and Varani, G. (2001) Curr. Opin. Struct. Biol. 11, 53-58[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Handa, N., Nureki, O., Kurimoto, K., Kim, I., Sakamoto, H., Shimura, Y., Muto, Y., and Yokoyama, S. (1999) Nature 398, 579-585[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Deo, R. C., Bonanno, J. B., Sonenberg, N., and Burley, S. K. (1999) Cell 98, 835-845[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Crowder, S. M.,
Kanaar, R.,
Rio, D. C.,
and Alber, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4892-4897 |
| 33. | Branden, C., and Tooze, J. (1991) Introduction to Protein Structure , Garland Publishing, Inc., New York |
| 34. | Cartegni, L., Maconi, M., Morandi, E., Cobianchi, F., Riva, S., and Biamonti, G. (1996) J. Mol. Biol. 259, 337-348[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | DiNitto, J. P., and Huber, P. W. (2001) Biochemistry 40, 12645-12653[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Kozlov, G.,
Trempe, J. F.,
Khaleghpour, K.,
Kahvejian, A.,
Ekiel, I.,
and Gehring, K.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
4409-4413 |
| 37. | Chen, C. Y., Gherzi, R., Ong, S. E., Chan, E. L., Raijmakers, R., Pruijn, G. J., Stoecklin, G., Moroni, C., Mann, M., and Karin, M. (2001) Cell 107, 451-464[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680 |